Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group - Pritchard, K I; Paterson, A H; Paul, N A (J Clin Oncol, 1996)
et al.